Transcatheter mitral valve repair ‘improves survival better than meds alone’
US doctors say the minimally invasive procedure also reduced hospitalisations from heart failure during five years' follow-up.
Transcatheter edge-to-edge repair of severe mitral regurgitation prolongs survival and cuts hospital admissions through five years’ follow-up better than medical therapy alone, a large study shows.
US doctors report a 47% lower risk of death or hospitalisation for heart failure (HF) in patients who underwent the minimally invasive procedure with the MitraClip device compared to controls.
